SkepBioInvestor’s Activity

Thu Sep 11

CAPS Underperform Pitch Reply

SkepBioInvestor commented on asilverp's pitch for MDVN. 2:59 PM

Medivation is already profitable, and FCF positive. It'll be taken out by Astellas after data from breast cancer trial.

Mon Aug 4

CAPS Outperform Pitch

SkepBioInvestor wrote about Amicus Therapeutics, Inc. (FOLD) . 4:33 PM

FOLD Outperform

Positive migalastat ph3 data and potential regulatory filings

Caps Pick

SkepBioInvestor made a pick in CAPS. 4:33 PM

Amicus Therapeutics, Inc. (FOLD) will Outperform the S&P 500

Thu Jun 26

Caps Pick

SkepBioInvestor made a pick in CAPS. 5:22 PM

Epizyme (EPZM) will Outperform the S&P 500

CAPS Outperform Pitch

SkepBioInvestor wrote about Bluebird Bio Inc. (BLUE) . 5:21 PM

BLUE Outperform

Wall St darling

Caps Pick

SkepBioInvestor made a pick in CAPS. 5:21 PM

Bluebird Bio Inc. (BLUE) will Outperform the S&P 500

CAPS Outperform Pitch

SkepBioInvestor wrote about ARGOS THERAPEUTICS (ARGS) . 5:20 PM

ARGS Outperform

positive p2b HIV data

Caps Pick

SkepBioInvestor made a pick in CAPS. 5:20 PM

ARGOS THERAPEUTICS (ARGS) will Outperform the S&P 500

CAPS Stats & Trivia

CAPS Player Rating 95.81
Player Rank 3142 out of 75033
Score 1391.40
Score Change Today +10.94
Accuracy 66.67%
Active Picks 8
Total Picks 35
Best Pick ITMN (+481.16)
Worst Pick FOLD (-67.63)
Average Score per Pick 39.75
Charms Earned 8
Highest Rated Favorite No Favorites Selected
Go to SkepBioInvestor’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show SkepBioInvestor’s 10 Latest Posts